retatrutide amino acid sequence Research Guide: What the Phase 2 Trial Data Reported (2026) Retatrutide (LY3437943) | GCGR/GLP-1R Inhibitor

I hate this

In the UCLA RA study, GI side effects were the top reason patients discontinued

Thats one of the more recently FDA-approved GLP-1s for weight management indications

According to the 2024 American Diabetes Association Standards of Care, GLP-1 receptor agonists have become first line pharmacotherapy for most patients with type 2 diabetes mellitus (T2DM), including those with concomitant atherosclerotic cardiovascular disease (ASCVD), indicators of high ASCVD risk, or chronic kidney disease

Intermittent fasting This helped me remain in a calorie deficit throughout the month

471 The mechanisms by which SGLT2 inhibitors treat heart failure include lowering blood glucose levels by inhibiting the SGLT2 protein in the renal tubules and reducing glucose reabsorption in the tubules